<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>医药魔方Med | wechat-feeds</title><link>http://MzIwMTk2MDM3Ng.favicon.privacyhide.com/favicon.ico</link><description>Best Evidence, Best Benefit</description><managingEditor> (hellodword)</managingEditor><pubDate>Wed, 27 Jan 2021 13:42:26 +0800</pubDate><image><url>http://MzIwMTk2MDM3Ng.favicon.privacyhide.com/favicon.ico</url><title>医药魔方Med | wechat-feeds</title><link>http://MzIwMTk2MDM3Ng.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>2020肿瘤新药数据卡——奈拉替尼</title><link>https://mp.weixin.qq.com/s/C8mw2WiOwHhRahoABfIEjA</link><description></description><content:encoded><![CDATA[2020肿瘤新药数据卡——奈拉替尼]]></content:encoded><pubDate>Wed, 27 Jan 2021 12:15:43 +0800</pubDate></item><item><title>2020肿瘤新药数据卡——阿美替尼</title><link>https://mp.weixin.qq.com/s/CicHiFKpLG7DpC92V5Wu0g</link><description></description><content:encoded><![CDATA[2020肿瘤新药数据卡——阿美替尼]]></content:encoded><pubDate>Tue, 26 Jan 2021 11:05:06 +0800</pubDate></item><item><title>2020肿瘤新药数据卡——阿替利珠单抗</title><link>https://mp.weixin.qq.com/s/yzS363WMgoDB4Cpp-KLFyQ</link><description></description><content:encoded><![CDATA[2020肿瘤新药数据卡——阿替利珠单抗]]></content:encoded><pubDate>Mon, 25 Jan 2021 13:33:08 +0800</pubDate></item><item><title>医药魔方Med招聘：医学编辑</title><link>https://mp.weixin.qq.com/s/O-dmpSkPyQDtiVnPMJ4M1w</link><description></description><content:encoded><![CDATA[医药魔方Med招聘：医学编辑]]></content:encoded><pubDate>Sat, 23 Jan 2021 15:20:21 +0800</pubDate></item><item><title>肿瘤新药数据卡——恩美曲妥珠单抗</title><link>https://mp.weixin.qq.com/s/CaafdEXfXqv2OhojEY7w4A</link><description></description><content:encoded><![CDATA[肿瘤新药数据卡——恩美曲妥珠单抗]]></content:encoded><pubDate>Fri, 22 Jan 2021 12:10:02 +0800</pubDate></item><item><title>聚焦ASCO-GI：肝癌研究摘要选读</title><link>https://mp.weixin.qq.com/s/1Ko68gNcmwW7Bdic370mCg</link><description></description><content:encoded><![CDATA[聚焦ASCO-GI：肝癌研究摘要选读]]></content:encoded><pubDate>Thu, 21 Jan 2021 10:43:21 +0800</pubDate></item><item><title>二度失利！哌柏西利先发优势再遭挑战？</title><link>https://mp.weixin.qq.com/s/2PscT_VO3itsS0LSnl8wJQ</link><description></description><content:encoded><![CDATA[二度失利！哌柏西利先发优势再遭挑战？]]></content:encoded><pubDate>Wed, 20 Jan 2021 12:29:08 +0800</pubDate></item><item><title>JAMA子刊：社交媒体招募癌症患者？或许时机尚早</title><link>https://mp.weixin.qq.com/s/gcNN3aVyqYF1M3C1wmSoSA</link><description></description><content:encoded><![CDATA[JAMA子刊：社交媒体招募癌症患者？或许时机尚早]]></content:encoded><pubDate>Mon, 18 Jan 2021 15:00:36 +0800</pubDate></item><item><title>期中分析，临床研究的潘多拉魔盒？统计师心里苦…</title><link>https://mp.weixin.qq.com/s/C8qJ0ZOO1APRdmm40j107A</link><description></description><content:encoded><![CDATA[期中分析，临床研究的潘多拉魔盒？统计师心里苦…]]></content:encoded><pubDate>Fri, 15 Jan 2021 22:35:23 +0800</pubDate></item><item><title>医肿GCP中心Cancer Cell发文：实体瘤细胞/基因治疗全景图</title><link>https://mp.weixin.qq.com/s/sIxbq7fQWYy641XU9jsTlg</link><description></description><content:encoded><![CDATA[医肿GCP中心Cancer Cell发文：实体瘤细胞/基因治疗全景图]]></content:encoded><pubDate>Fri, 15 Jan 2021 12:02:41 +0800</pubDate></item></channel></rss>